This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Nov;1(8):1109-10.

doi: 10.1001/jamaoncol.2015.2719.

Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact

Allison W Kurian¹, Christopher R Friese²

Affiliations

Affiliations

¹ Department of Medicine, Stanford University School of Medicine, Stanford, California2Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
² Department of Systems, Populations and Leadership, University of Michigan School of Nursing, Ann Arbor4Institute for Healthcare Policy and Innovation, University of Michigan School of Nursing, Ann Arbor.

PMID: 26313021
DOI: 10.1001/jamaoncol.2015.2719

Comment

Precision Medicine in Breast Cancer Care: An Early Glimpse of Impact

Allison W Kurian et al. JAMA Oncol. 2015 Nov.

. 2015 Nov;1(8):1109-10.

doi: 10.1001/jamaoncol.2015.2719.

Authors

Allison W Kurian¹, Christopher R Friese²

Affiliations

¹ Department of Medicine, Stanford University School of Medicine, Stanford, California2Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.
² Department of Systems, Populations and Leadership, University of Michigan School of Nursing, Ann Arbor4Institute for Healthcare Policy and Innovation, University of Michigan School of Nursing, Ann Arbor.

PMID: 26313021
DOI: 10.1001/jamaoncol.2015.2719

No abstract available

PubMed Disclaimer

Comment on

Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH. Dinan MA, et al. JAMA Oncol. 2015 Nov;1(8):1098-109. doi: 10.1001/jamaoncol.2015.2722. JAMA Oncol. 2015. PMID: 26313372

Similar articles

Chemotherapy and the recurrence score--results as expected?
Pusztai L. Pusztai L. Nat Rev Clin Oncol. 2015 Dec;12(12):690-2. doi: 10.1038/nrclinonc.2015.191. Epub 2015 Nov 10. Nat Rev Clin Oncol. 2015. PMID: 26552957 No abstract available.
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009.
Dinan MA, Mi X, Reed SD, Lyman GH, Curtis LH. Dinan MA, et al. JAMA Oncol. 2015 Nov;1(8):1098-109. doi: 10.1001/jamaoncol.2015.2722. JAMA Oncol. 2015. PMID: 26313372
Breast cancer and genomic testing.
Liedtke C, Kolberg HC. Liedtke C, et al. Br J Surg. 2017 Jun;104(7):799-801. doi: 10.1002/bjs.10513. Epub 2017 Mar 16. Br J Surg. 2017. PMID: 28300277 No abstract available.
[Gene signatures for breast cancer, clinical utility and therapeutic applications].
Vargas-Aguilar VM, Arroyo-Alvarez K. Vargas-Aguilar VM, et al. Rev Med Inst Mex Seguro Soc. 2018 Mar-Apr;56(2):180-185. Rev Med Inst Mex Seguro Soc. 2018. PMID: 29906029 Review. Spanish.
Multigene prognostic tests in breast cancer: past, present, future.
Győrffy B, Hatzis C, Sanft T, Hofstatter E, Aktas B, Pusztai L. Győrffy B, et al. Breast Cancer Res. 2015 Jan 27;17(1):11. doi: 10.1186/s13058-015-0514-2. Breast Cancer Res. 2015. PMID: 25848861 Free PMC article. Review.

See all similar articles

Cited by

Success Factors and Barriers in Combining Personalized Medicine and Patient Centered Care in Breast Cancer. Results from a Systematic Review and Proposal of Conceptual Framework.
de Belvis AG, Pellegrino R, Castagna C, Morsella A, Pastorino R, Boccia S. de Belvis AG, et al. J Pers Med. 2021 Jul 13;11(7):654. doi: 10.3390/jpm11070654. J Pers Med. 2021. PMID: 34357121 Free PMC article. Review.
Automated volumetric radiomic analysis of breast cancer vascularization improves survival prediction in primary breast cancer.
Dietzel M, Schulz-Wendtland R, Ellmann S, Zoubi R, Wenkel E, Hammon M, Clauser P, Uder M, Runnebaum IB, Baltzer PAT. Dietzel M, et al. Sci Rep. 2020 Feb 28;10(1):3664. doi: 10.1038/s41598-020-60393-9. Sci Rep. 2020. PMID: 32111898 Free PMC article.
Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet.
Ngeow J, Eng C. Ngeow J, et al. NPJ Genom Med. 2016 Jan 13;1:15006. doi: 10.1038/npjgenmed.2015.6. eCollection 2016. NPJ Genom Med. 2016. PMID: 29263804 Free PMC article.
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.
Zheng PP, Li J, Kros JM. Zheng PP, et al. Med Res Rev. 2018 Jan;38(1):325-376. doi: 10.1002/med.21463. Epub 2017 Sep 1. Med Res Rev. 2018. PMID: 28862319 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information